Scinovex
article Open AccessTop 1% cited

European Association of Urology Guidelines on Renal Cell Carcinoma: The 2022 Update

European Urology · 2022 · Vol. 82(4) · pp. 399–410
Börje LjungbergLaurence AlbigèsYasmin Abu‐GhanemJens BedkeUmberto CapitanioSaeed DabestaniSergio Fernandéz‐PelloRachel GilesFabian HofmannMilan HoraTobias KlatteTeele KuuskThomas LamLorenzo MarconiThomas PowlesRana TahbazAlessandro VolpeAxel Bex

Abstract

The European Association of Urology panel for guidelines on kidney cancer has thoroughly evaluated the research data available to establish up-to-date international standards for the care of patients with kidney cancer.

Renal cell carcinoma treatmentRenal and related cancersEconomic and Financial Impacts of CancerMedicineGuidelineMEDLINERenal cell carcinomaSystematic reviewCochrane LibraryEvidence-based medicineKidney cancerRandomized controlled trialInternal medicine

MeSH terms

Carcinoma, Renal CellHumansKidney NeoplasmsUrology

Funding

  • Amgen
  • Bristol-Myers Squibb
  • Pfizer
  • Astellas Pharma US
  • AstraZeneca
  • Bayer
  • GlaxoSmithKline
  • Merck
  • Novartis
  • Roche
  • Sanofi
  • Meso Scale Diagnostics
  • Exelixis
  • Incyte
  • Eisai
  • Astellas Pharma
  • Ipsen
  • Johnson and Johnson
  • EMD Serono
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.